Indian Emulsifiers MD, chairman and AGM

Indian Emulsifiers board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

Statutory auditor

Named in the results for the quarter to Mar 2026.

DAVE & DAVEPeer-review certificate valid to Mar 2028

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Indian Emulsifiers AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Indian Emulsifiers share news and announcements

Annual general meeting, 30 Sep 2026

3,357 shareholders on the register on 23 Sep 2026; present: 1 promoter and 14 others; votes counted by Nikunj Kanabar / Nikunj Kanabar & Associates.The company's voting result (opens in a new tab)

To receive, consider, and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, and the Reports of the Board of Directors and the Auditors thereon.MoreLess
Ordinary
99.47% for0.53% against
Against: promoters 0.00% · institutions 0.00% · other public 12.22%
Turnout: all 34.12% · promoters 100.00% · institutions 0.00% · other public 2.33%
To appoint Mr. Rajesh Madhukar Joshi (DIN: 06533262), Non Executive Director, who retires by rotation and, being eligible, offers himself for re-appointment.
Ordinary
99.47% for0.53% against
Against: promoters 0.00% · institutions 0.00% · other public 12.22%
Turnout: all 34.12% · promoters 100.00% · institutions 0.00% · other public 2.33%
Ratification of remuneration payable to M/s. Narendra Peshne & Associates, Cost Auditor of the Company.
Ordinary
99.30% for0.70% against
Against: promoters 0.00% · institutions 0.00% · other public 16.08%
Turnout: all 34.12% · promoters 100.00% · institutions 0.00% · other public 2.33%
To approve material related party transactions with M/s Chemical Brothers Enterprises Private Limited.
OrdinaryPromoters have an interest in it
54.14% for45.86% against
Against: promoters 0.00% · institutions 0.00% · other public 45.86%
Turnout: all 1.48% · promoters 0.00% · institutions 0.00% · other public 2.33%
To approve material related party transactions with M/s YST Life Sciences Private Limited.
OrdinaryPromoters have an interest in it
54.14% for45.86% against
Against: promoters 0.00% · institutions 0.00% · other public 45.86%
Turnout: all 1.48% · promoters 0.00% · institutions 0.00% · other public 2.33%
To increase the borrowing limit under Section 180(1)(c) of the Companies Act, 2013.
Special
99.24% for0.76% against
Against: promoters 0.00% · institutions 0.00% · other public 17.47%
Turnout: all 34.11% · promoters 100.00% · institutions 0.00% · other public 2.31%
Approval under Section 180(1)(a) of the Companies Act, 2013.
Special
99.47% for0.53% against
Against: promoters 0.00% · institutions 0.00% · other public 12.22%
Turnout: all 34.12% · promoters 100.00% · institutions 0.00% · other public 2.33%
To increase limits for loans, guarantees, and investments under Section 186 of the Companies Act, 2013.
Special
99.08% for0.92% against
Against: promoters 0.00% · institutions 0.00% · other public 21.23%
Turnout: all 34.12% · promoters 100.00% · institutions 0.00% · other public 2.33%
To increase the Authorised Share Capital and consequent alteration of the Memorandum of Association of the Company.
Ordinary
98.01% for1.99% against
Against: promoters 0.00% · institutions 0.00% · other public 45.86%
Turnout: all 34.12% · promoters 100.00% · institutions 0.00% · other public 2.33%
Change in designation of Mr. Abhay Tikekar (DIN: 10425123) from Whole-Time Director to ‘Executive Director’
Ordinary
98.40% for1.60% against
Against: promoters 0.00% · institutions 0.00% · other public 36.86%
Turnout: all 34.12% · promoters 100.00% · institutions 0.00% · other public 2.33%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 1 May 2026, 1 resolution

2,827 shareholders on the register on 27 Mar 2026; votes counted by Nikunj Kanabar / M/S. NIKUNJ KANABAR & ASSOCIATES.The company's voting result (opens in a new tab)

INCREASE IN AUTHORISED SHARE CAPITAL AND CONSEQUENT ALTERATION OF CAPITAL CLAUSE OF MEMORANDUM OF ASSOCIATION.
Ordinary
99.64% for0.36% against
Against: promoters 0.00% · institutions 0.00% · other public 17.41%
Turnout: all 33.32% · promoters 100.00% · institutions 0.00% · other public 1.10%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Dealings with its subsidiaries, promoters, directors and their firms, reported every half-year.Promoters and their stake

Half-year to Mar 2026: ₹12.0 Cr15 dealings
Half-year to Sep 2025: ₹18.3 Cr13 dealings
Half-year to Mar 2025: ₹9.4 Cr10 dealings

Between	Dealing
Indian Emulsifiers Limited and Chemical Brothers Private LimitedAssociate Concern	Sale of goods or services	5.30	0.00	0.00
Indian Emulsifiers Limited and YST Life Sciences Private LimitedAssociate Concern	Sale of goods or services	2.09	0.00	0.00
Indian Emulsifiers Limited and YST Surfactants Private LimitedAssociate Concern	Purchase of goods or services	1.56	0.00	0.00
Indian Emulsifiers Limited and YST Life Sciences Private LimitedAssociate Concern	Purchase of goods or services	1.14	0.07	6.88
Indian Emulsifiers Limited and Polaris Speciality Chemicals IncForeign Subsidiary	Sale of goods or services	0.56	0.00	0.56
Indian Emulsifiers Limited and Abhay TikekarDirector	Remuneration	0.51	0.07	0.00
Indian Emulsifiers Limited and Yash TikekarDirector	Remuneration	0.49	0.27	0.00
Indian Emulsifiers Limited and Southers Emulsifiers Solutions Pty LtdForeign Subsidiary	Advance	0.10	0.00	0.10
Indian Emulsifiers Limited and Southers Emulsifiers Solutions Pty LtdForeign Subsidiary	Purchase of goods or services	0.09	0.00	0.00
Indian Emulsifiers Limited and Yash TikekarDirector	Loan	0.05	0.16	0.21
Indian Emulsifiers Limited and VRT Enterprises Private limitedAssociate Concern	Loan	0.05	0.11	0.06
Indian Emulsifiers Limited and Chemical Brothers Private LimitedAssociate Concern	Any other transactionRent	0.03	0.00	₹43,000
Indian Emulsifiers Limited and Southers Emulsifiers Solutions Pty LtdForeign Subsidiary	Sale of goods or services	0.02	0.52	0.00
Indian Emulsifiers Limited and YST Surfactants Private LimitedAssociate Concern	Sale of goods or services	0.00	10.22	11.78
Indian Emulsifiers Limited and Chemical Brothers Private LimitedAssociate Concern	Purchase of goods or services	0.00	3.19	1.09

The 15 largest of 15 dealings in the half-year to Mar 2026, ₹ crore.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

Received
Resolved

Open at the quarter's end

None open at any quarter's end.

The filing has a part on fines and penalties: No
The filing has a part on tax disputes: No

The company's own answers in its filing.

How money raised was used

Reported for the quarter to Mar 2026. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far.

Raised	Amount raised	For	Set aside	Spent	Spent elsewhere
Rights IssuesNov 2025, checked by Infomerics Valuation and Rating Limited	48.89	To meet incremental working capital requirements	19.45	19.45	No
Rights IssuesNov 2025, checked by Infomerics Valuation and Rating Limited	48.89	Funding capital expenditure requirements for construction of new factory premises	5.94	4.50	No
Rights IssuesNov 2025, checked by Infomerics Valuation and Rating Limited	48.89	Funding capital expenditure requirements for the purchase of equipment/ machineries	11.36	10.53	No
Rights IssuesNov 2025, checked by Infomerics Valuation and Rating Limited	48.89	General Corporate Purposes	10.64	10.64	No
Rights IssuesNov 2025, checked by Infomerics Valuation and Rating Limited	48.89	Issue related expense	1.50	0.90	No

₹ crore. Checked by is the agency appointed to monitor how the money is used. The reason and the comments are the company's, its audit committee's and its auditors' own words.